- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
52
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
52 companies
Gilead Sciences
Market Cap: US$155.4b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$123.84
7D
0.06%
1Y
15.1%
CSL
Market Cap: AU$56.3b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$114.87
7D
-1.2%
1Y
-51.0%
Royalty Pharma
Market Cap: US$31.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$54.69
7D
3.3%
1Y
55.1%
Grifols
Market Cap: €5.5b
Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
GRF
€9.09
7D
0.9%
1Y
-11.3%
Organon
Market Cap: US$3.5b
Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$13.47
7D
0.3%
1Y
35.0%
China Medical System Holdings
Market Cap: HK$24.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$9.93
7D
-4.5%
1Y
-17.3%
Hypera
Market Cap: R$14.8b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.08
7D
4.3%
1Y
-21.5%
Grand Pharmaceutical Group
Market Cap: HK$16.3b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$4.57
7D
-4.8%
1Y
-47.0%
ADMA Biologics
Market Cap: US$2.0b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$8.72
7D
4.9%
1Y
-52.6%
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States.
HRMY
US$34.13
7D
2.6%
1Y
7.1%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩252,500.00
7D
4.3%
1Y
-31.6%
ANI Pharmaceuticals
Market Cap: US$1.8b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$83.28
7D
4.8%
1Y
26.5%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥11.5b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥6.84
7D
-4.3%
1Y
-38.1%
Bora Pharmaceuticals
Market Cap: NT$53.4b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$410.00
7D
-3.0%
1Y
-39.8%
Zhejiang Medicine
Market Cap: CN¥11.0b
Manufactures and sells life nutrition and pharmaceuticals products in China and internationally.
600216
CN¥11.29
7D
-2.0%
1Y
-21.7%
Square Pharmaceuticals
Market Cap: ৳198.7b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳224.10
7D
1.6%
1Y
6.7%
Lotus Pharmaceutical
Market Cap: NT$49.7b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$183.00
7D
-5.2%
1Y
-16.8%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€72.90
7D
5.1%
1Y
-7.6%
Consun Pharmaceutical Group
Market Cap: HK$10.8b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$12.48
7D
-6.3%
1Y
9.3%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥9.2b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥12.86
7D
0.2%
1Y
-23.7%
Collegium Pharmaceutical
Market Cap: US$1.2b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$34.84
7D
3.9%
1Y
16.5%
Aurisco PharmaceuticalLtd
Market Cap: CN¥7.7b
Engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide.
605116
CN¥18.85
7D
-3.6%
1Y
-8.8%
Strides Pharma Science
Market Cap: ₹99.7b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹1,082.20
7D
-2.6%
1Y
22.0%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$7.8b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China, the United States, and internationally.
460
HK$0.83
7D
-4.6%
1Y
-25.2%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥6.5b
Engages in the pharmaceutical business in China.
000915
CN¥27.00
7D
-0.2%
1Y
-16.8%
Luye Pharma Group
Market Cap: HK$7.3b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$1.78
7D
-10.1%
1Y
-49.1%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩35,150.00
7D
-5.4%
1Y
18.2%
Shanghai Haohai Biological Technology
Market Cap: HK$7.1b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$15.23
7D
-5.2%
1Y
-38.3%
Genomma Lab Internacional. de
Market Cap: Mex$14.3b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$15.09
7D
3.2%
1Y
-27.7%
SSY Group
Market Cap: HK$6.2b
An investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.11
7D
-0.9%
1Y
-23.3%
Zevra Therapeutics
Market Cap: US$773.2m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$13.23
7D
2.6%
1Y
42.6%
Omeros
Market Cap: US$765.7m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$10.72
7D
4.3%
1Y
222.9%
China Shineway Pharmaceutical Group
Market Cap: HK$5.7b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.43
7D
-2.5%
1Y
-4.7%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$5.3b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.
3613
HK$6.21
7D
-4.9%
1Y
-28.0%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥4.0b
Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.
603998
CN¥8.85
7D
-5.3%
1Y
-9.6%
DongKook Pharmaceutical
Market Cap: ₩804.8b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩17,030.00
7D
-6.6%
1Y
0.3%